Shah Metacorp (SHAH)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Low debt-to-equity of 0.21 indicates a conservative balance sheet
• Sales growth of 25.54% shows some demand momentum in the business
• Latest quarter is profitable, with net profit of ₹1 Cr on sales of ₹50 Cr
• ROCE of 7.63% is positive and above the company's debt cost implied by low leverage

Concerns

• Profit growth of -77% with a P/E of 56.45 suggests severe overvaluation
• ROE of 4.60% is far below the P/B of 2.96, meaning shareholders earn little on inflated book value
• Promoter holding of just 29.15% raises governance and alignment concerns
• Zero dividend yield and Piotroski F-score of 4/9 offer no income or fundamental support

AI Analysis

When I look at Shah Metacorp, I try to apply the simple tests I have used for decades. First, can I understand it? Yes, it is an iron and steel products company. But understanding the business is not enough; I need a margin of safety. At ₹5.30, the market capitalisation is ₹435 Cr, and I am being asked to pay 56.45 times earnings. That is a rich price for a company whose profit fell 77%. Graham would call this speculation, not investment. The book value is ₹1.79, so I am paying 2.96 times book for a return on equity of just 4.60%. That tells me the assets are not earning a satisfactory return. Even ROCE is only 7.63%, barely acceptable. The latest quarter shows sales of ₹50 Cr but net profit of just ₹1 Cr, a 2% margin. That is no pricing power. Sales growth of 25.54% looks encouraging, but in steel, cycles drive top lines; profits are what matter, and they are collapsing. The Piotroski F-score of 4 out of 9 also signals weak fundamental health. On the positive side, debt-to-equity is low at 0.21, so the balance sheet is not stretched. But with no dividend and promoter holding of only 29.15%, I do not see strong alignment or income to compensate for risk. The stock trades near the upper end of its 52-week range, ₹5.30 versus a low of ₹3.10. That is the wrong part of the cycle to chase. This is a cyclical commodity business, and I am not being compensated for the cyclicality. I would rather wait for a lower valuation and evidence that returns are improving. For now, this is a pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer